Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	DCHS2 CLSTN3 CDHR1 FAT3 PCDHB13 PCDHB8 F9 CRB1 PITPNM1 FAT1 CELSR1 FAT2 ACAN VCAN PCDH15 ADGRE1 CDH4	1.02e-05	749	133	17	GO:0005509
GeneOntologyMolecularFunction	neurexin family protein binding	CLSTN3 NLGN1 NLGN2	1.52e-04	16	133	3	GO:0042043
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	DCHS2 CLSTN3 SDK2 CDHR1 FAT3 PCDHB13 PCDHB8 FAT1 CELSR1 FAT2 TENM3 PCDH15 CDH4	2.31e-10	187	132	13	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DCHS2 CLSTN3 SDK2 CDHR1 FAT3 PCDHB13 PCDHB8 NLGN1 CRB1 FAT1 CELSR1 FAT2 TENM3 PCDH15 CDH4	1.63e-09	313	132	15	GO:0098742
GeneOntologyBiologicalProcess	cell-cell adhesion	DCHS2 CLSTN3 SDK2 RAP1GAP CDHR1 FAT3 PKD1L1 PCDHB13 PCDHB8 NLGN1 CRB1 FAT1 CELSR1 FAT2 TENM3 PCDH15 PKHD1 COL14A1 NLGN2 CTNND2 CDH4	4.79e-06	1077	132	21	GO:0098609
GeneOntologyBiologicalProcess	positive regulation of protein localization to synapse	CLSTN3 NLGN1 NLGN2	1.40e-05	8	132	3	GO:1902474
GeneOntologyBiologicalProcess	positive regulation of synaptic vesicle clustering	NLGN1 SNAP91 NLGN2	1.40e-05	8	132	3	GO:2000809
GeneOntologyBiologicalProcess	terminal button organization	NLGN1 SNAP91 NLGN2	2.09e-05	9	132	3	GO:0072553
GeneOntologyBiologicalProcess	synapse organization	IL10RA RELN CLSTN3 SDK2 IQSEC2 PCDHB13 ADGRB1 PCDHB8 SYBU NLGN1 TENM3 SNAP91 NFIA NLGN2 CTNND2	3.34e-05	685	132	15	GO:0050808
GeneOntologyBiologicalProcess	postsynaptic density protein 95 clustering	RELN NLGN1 NLGN2	4.07e-05	11	132	3	GO:0097119
GeneOntologyBiologicalProcess	cell junction organization	IL10RA RELN CLSTN3 SDK2 IQSEC2 PCDHB13 ADGRB1 PCDHB8 SYBU NLGN1 TENM3 SNAP91 NFIA PKHD1 PRKCH NLGN2 CTNND2 CDH4	4.95e-05	974	132	18	GO:0034330
GeneOntologyBiologicalProcess	regulation of synaptic vesicle clustering	NLGN1 SNAP91 NLGN2	5.40e-05	12	132	3	GO:2000807
GeneOntologyBiologicalProcess	positive regulation of nervous system development	RELN CLSTN3 IQSEC2 ADGRB1 NLGN1 SNAP91 ACAN VCAN PRKCH NLGN2 CDH4	8.00e-05	418	132	11	GO:0051962
GeneOntologyBiologicalProcess	anterograde trans-synaptic signaling	CACNA1C RELN CLSTN3 IQSEC2 PCDHB13 ADGRB1 PCDHB8 SYBU NLGN1 SLC1A4 P2RX3 SNAP91 VPS13A SORCS3 NLGN2 CTNND2 ALG13	9.44e-05	931	132	17	GO:0098916
GeneOntologyBiologicalProcess	chemical synaptic transmission	CACNA1C RELN CLSTN3 IQSEC2 PCDHB13 ADGRB1 PCDHB8 SYBU NLGN1 SLC1A4 P2RX3 SNAP91 VPS13A SORCS3 NLGN2 CTNND2 ALG13	9.44e-05	931	132	17	GO:0007268
GeneOntologyBiologicalProcess	regulation of protein localization to synapse	CLSTN3 IQSEC2 NLGN1 NLGN2	9.99e-05	38	132	4	GO:1902473
GeneOntologyBiologicalProcess	trans-synaptic signaling	CACNA1C RELN CLSTN3 IQSEC2 PCDHB13 ADGRB1 PCDHB8 SYBU NLGN1 SLC1A4 P2RX3 SNAP91 VPS13A SORCS3 NLGN2 CTNND2 ALG13	1.05e-04	939	132	17	GO:0099537
GeneOntologyBiologicalProcess	photoreceptor cell outer segment organization	IFT140 CDHR1 CRB1	1.10e-04	15	132	3	GO:0035845
GeneOntologyBiologicalProcess	regulation of synaptic plasticity	RELN IQSEC2 ADGRB1 NLGN1 P2RX3 VPS13A SORCS3 CTNND2 ALG13	1.15e-04	293	132	9	GO:0048167
GeneOntologyBiologicalProcess	positive regulation of synaptic transmission, glutamatergic	RELN IQSEC2 NLGN1 NLGN2	1.63e-04	43	132	4	GO:0051968
GeneOntologyBiologicalProcess	synaptic signaling	CACNA1C RELN CLSTN3 IQSEC2 PCDHB13 ADGRB1 PCDHB8 SYBU NLGN1 SLC1A4 P2RX3 SNAP91 VPS13A SORCS3 NLGN2 CTNND2 ALG13	1.66e-04	976	132	17	GO:0099536
GeneOntologyBiologicalProcess	synapse assembly	RELN CLSTN3 SDK2 IQSEC2 PCDHB13 ADGRB1 PCDHB8 NLGN1 NLGN2	1.67e-04	308	132	9	GO:0007416
GeneOntologyBiologicalProcess	synaptic transmission, glutamatergic	RELN CLSTN3 IQSEC2 NLGN1 SLC1A4 NLGN2	2.08e-04	132	132	6	GO:0035249
GeneOntologyBiologicalProcess	regulation of presynapse organization	CLSTN3 NLGN1 SNAP91 NLGN2	2.12e-04	46	132	4	GO:0099174
GeneOntologyBiologicalProcess	excitatory synapse assembly	RELN CLSTN3 NLGN1 NLGN2	2.12e-04	46	132	4	GO:1904861
GeneOntologyBiologicalProcess	positive regulation of synapse assembly	CLSTN3 IQSEC2 ADGRB1 NLGN1 NLGN2	2.29e-04	86	132	5	GO:0051965
GeneOntologyBiologicalProcess	regulation of synaptic activity	RELN SYBU	2.42e-04	4	132	2	GO:0060025
GeneOntologyBiologicalProcess	synapse maturation	RELN SYBU NLGN1 NFIA	2.94e-04	50	132	4	GO:0060074
GeneOntologyBiologicalProcess	neurotransmitter-gated ion channel clustering	RELN NLGN1 NLGN2	3.61e-04	22	132	3	GO:0072578
GeneOntologyBiologicalProcess	synaptic vesicle clustering	NLGN1 SNAP91 NLGN2	3.61e-04	22	132	3	GO:0097091
GeneOntologyBiologicalProcess	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	PCDHB13 PCDHB8 NLGN1 CDH4	3.68e-04	53	132	4	GO:0016339
GeneOntologyBiologicalProcess	positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	CACNA1C CACNA1D	4.01e-04	5	132	2	GO:1904879
GeneOntologyBiologicalProcess	retina layer formation	SDK2 FAT3 CRB1	5.32e-04	25	132	3	GO:0010842
GeneOntologyBiologicalProcess	regulation of AMPA receptor activity	RELN NLGN1 NLGN2	5.32e-04	25	132	3	GO:2000311
GeneOntologyBiologicalProcess	NMDA glutamate receptor clustering	RELN NLGN1	6.00e-04	6	132	2	GO:0097114
GeneOntologyBiologicalProcess	cell morphogenesis	RELN CLSTN3 CDHR1 FAT3 ADGRB1 OSTN NLGN1 CRB1 FAT1 LLGL1 SNAP91 NFIA PTPRQ VPS13A PCDH15 PKHD1 CTNND2 CDH4	6.07e-04	1194	132	18	GO:0000902
GeneOntologyBiologicalProcess	regulation of respiratory gaseous exchange	NLGN1 NLGN2 NMBR	6.70e-04	27	132	3	GO:0043576
GeneOntologyBiologicalProcess	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	NLGN1 CRB1 TENM3 CDH4	7.13e-04	63	132	4	GO:0007157
GeneOntologyCellularComponent	non-motile cilium	IFT140 CDHR1 PKD1L1 PCDHB13 PCDHB8 CRB1 VCAN PCDH15 PKHD1 MERTK	5.56e-07	196	134	10	GO:0097730
GeneOntologyCellularComponent	photoreceptor outer segment	IFT140 CDHR1 PCDHB13 PCDHB8 CRB1 VCAN PCDH15 MERTK	5.86e-07	111	134	8	GO:0001750
GeneOntologyCellularComponent	9+0 non-motile cilium	IFT140 CDHR1 PCDHB13 PCDHB8 CRB1 VCAN PCDH15 PKHD1 MERTK	6.37e-07	153	134	9	GO:0097731
GeneOntologyCellularComponent	photoreceptor cell cilium	IFT140 CDHR1 PCDHB13 PCDHB8 CRB1 VCAN PCDH15 MERTK	3.22e-06	139	134	8	GO:0097733
GeneOntologyCellularComponent	Golgi lumen	MUC19 MUC16 F9 ACAN VCAN SDC1 MUC20	6.57e-06	109	134	7	GO:0005796
GeneOntologyCellularComponent	synaptic membrane	CACNA1C CACNA1D CLSTN3 IQSEC2 PCDHB13 ADGRB1 PCDHB8 NLGN1 P2RX3 TENM3 SNAP91 SORCS3 NLGN2	9.80e-05	583	134	13	GO:0097060
GeneOntologyCellularComponent	cilium	CFAP47 IFT140 TPPP2 CDHR1 PKD1L1 PCDHB13 PCDHB8 NPFFR1 ADCY6 CRB1 VCAN VPS13A PCDH15 PKHD1 MERTK SUFU	2.08e-04	898	134	16	GO:0005929
GeneOntologyCellularComponent	postsynaptic membrane	CACNA1C CLSTN3 IQSEC2 PCDHB13 ADGRB1 PCDHB8 NLGN1 SNAP91 SORCS3 NLGN2	2.88e-04	405	134	10	GO:0045211
GeneOntologyCellularComponent	actin-based cell projection	NLGN1 ADCY6 CRB1 FAT1 PTPRQ PCDH15 MTTP MUC20	4.35e-04	278	134	8	GO:0098858
GeneOntologyCellularComponent	neuron to neuron synapse	CACNA1C CLSTN3 IQSEC2 ADGRB1 NLGN1 P2RX3 SNAP91 MIB1 SORCS3 NLGN2 CTNND2	5.58e-04	523	134	11	GO:0098984
GeneOntologyCellularComponent	interphotoreceptor matrix	RBP3 VCAN	6.02e-04	6	134	2	GO:0033165
GeneOntologyCellularComponent	lipid droplet	CLSTN3 ATG2B NSDHL PITPNM1 VPS13A	9.12e-04	116	134	5	GO:0005811
GeneOntologyCellularComponent	ribbon synapse	CACNA1D IQSEC2 NLGN2	1.12e-03	32	134	3	GO:0097470
GeneOntologyCellularComponent	postsynaptic specialization	CACNA1C CLSTN3 IQSEC2 ADGRB1 NLGN1 SNAP91 MIB1 SORCS3 NLGN2 CTNND2	1.52e-03	503	134	10	GO:0099572
GeneOntologyCellularComponent	perineuronal net	ACAN VCAN	1.77e-03	10	134	2	GO:0072534
GeneOntologyCellularComponent	microvillus membrane	ADCY6 MTTP MUC20	1.84e-03	38	134	3	GO:0031528
GeneOntologyCellularComponent	postsynaptic specialization membrane	CACNA1C CLSTN3 IQSEC2 NLGN1 SORCS3 NLGN2	1.90e-03	201	134	6	GO:0099634
GeneOntologyCellularComponent	perisynaptic extracellular matrix	ACAN VCAN	2.16e-03	11	134	2	GO:0098966
GeneOntologyCellularComponent	postsynaptic density	CACNA1C CLSTN3 IQSEC2 ADGRB1 NLGN1 SNAP91 MIB1 SORCS3 CTNND2	2.54e-03	451	134	9	GO:0014069
GeneOntologyCellularComponent	L-type voltage-gated calcium channel complex	CACNA1C CACNA1D	2.58e-03	12	134	2	GO:1990454
Domain	CADHERIN_1	DCHS2 CLSTN3 CDHR1 FAT3 PCDHB13 PCDHB8 FAT1 CELSR1 FAT2 PCDH15 CDH4	4.19e-10	113	131	11	PS00232
Domain	Cadherin	DCHS2 CLSTN3 CDHR1 FAT3 PCDHB13 PCDHB8 FAT1 CELSR1 FAT2 PCDH15 CDH4	4.19e-10	113	131	11	PF00028
Domain	CADHERIN_2	DCHS2 CLSTN3 CDHR1 FAT3 PCDHB13 PCDHB8 FAT1 CELSR1 FAT2 PCDH15 CDH4	4.61e-10	114	131	11	PS50268
Domain	-	DCHS2 CLSTN3 CDHR1 FAT3 PCDHB13 PCDHB8 FAT1 CELSR1 FAT2 PCDH15 CDH4	4.61e-10	114	131	11	2.60.40.60
Domain	CA	DCHS2 CLSTN3 CDHR1 FAT3 PCDHB13 PCDHB8 FAT1 CELSR1 FAT2 PCDH15 CDH4	5.07e-10	115	131	11	SM00112
Domain	Cadherin-like	DCHS2 CLSTN3 CDHR1 FAT3 PCDHB13 PCDHB8 FAT1 CELSR1 FAT2 PCDH15 CDH4	5.56e-10	116	131	11	IPR015919
Domain	Cadherin	DCHS2 CLSTN3 CDHR1 FAT3 PCDHB13 PCDHB8 FAT1 CELSR1 FAT2 PCDH15 CDH4	6.69e-10	118	131	11	IPR002126
Domain	Cadherin_CS	DCHS2 CDHR1 FAT3 PCDHB13 PCDHB8 FAT1 CELSR1 FAT2 PCDH15 CDH4	4.82e-09	109	131	10	IPR020894
Domain	EGF	FRAS1 RELN FAT3 F9 CRB1 MEP1B FAT1 CELSR1 FAT2 FCGBP TENM3 VCAN ADGRE1	1.11e-08	235	131	13	SM00181
Domain	EGF-like_dom	FRAS1 RELN FAT3 F9 CRB1 MEP1B FAT1 CELSR1 FAT2 FCGBP TENM3 VCAN ADGRE1	2.21e-08	249	131	13	IPR000742
Domain	ConA-like_dom	CLSTN3 FAT3 CMYA5 ADGRG4 CRB1 MEP1B FAT1 CELSR1 FAT2 TRIM62 COL14A1 NEURL4	4.66e-08	219	131	12	IPR013320
Domain	EGF_3	RELN FAT3 F9 CRB1 MEP1B FAT1 CELSR1 FAT2 TENM3 VCAN ADGRE1	8.35e-07	235	131	11	PS50026
Domain	EGF_1	RELN FAT3 F9 CRB1 MEP1B FAT1 CELSR1 FAT2 TENM3 VCAN ADGRE1	1.86e-06	255	131	11	PS00022
Domain	EGF-like_CS	RELN FAT3 F9 CRB1 MEP1B FAT1 CELSR1 FAT2 TENM3 VCAN ADGRE1	2.33e-06	261	131	11	IPR013032
Domain	EGF_CA	FAT3 F9 CRB1 FAT1 CELSR1 FAT2 VCAN ADGRE1	2.33e-06	122	131	8	SM00179
Domain	EGF-like_Ca-bd_dom	FAT3 F9 CRB1 FAT1 CELSR1 FAT2 VCAN ADGRE1	2.63e-06	124	131	8	IPR001881
Domain	EGF_2	RELN FAT3 F9 CRB1 MEP1B FAT1 CELSR1 FAT2 TENM3 VCAN ADGRE1	2.69e-06	265	131	11	PS01186
Domain	Laminin_G	FAT3 CRB1 FAT1 CELSR1 FAT2 COL14A1	3.19e-06	58	131	6	IPR001791
Domain	-	CLSTN3 FAT3 ADGRG4 CRB1 FAT1 CELSR1 FAT2	4.70e-06	95	131	7	2.60.120.200
Domain	GPS	PKD1L1 ADGRB1 ADGRG4 CELSR1 ADGRE1	4.98e-06	36	131	5	PS50221
Domain	GPS	PKD1L1 ADGRB1 ADGRG4 CELSR1 ADGRE1	5.72e-06	37	131	5	IPR000203
Domain	LAM_G_DOMAIN	FAT3 CRB1 FAT1 CELSR1 FAT2	6.55e-06	38	131	5	PS50025
Domain	ASX_HYDROXYL	FAT3 F9 CRB1 FAT1 CELSR1 VCAN ADGRE1	6.62e-06	100	131	7	PS00010
Domain	Laminin_G_2	FAT3 CRB1 FAT1 CELSR1 FAT2	8.50e-06	40	131	5	PF02210
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT3 F9 CRB1 FAT1 CELSR1 VCAN ADGRE1	9.73e-06	106	131	7	IPR000152
Domain	LamG	FAT3 CRB1 FAT1 CELSR1 FAT2	1.37e-05	44	131	5	SM00282
Domain	EGF	F9 CRB1 MEP1B FAT1 CELSR1 FAT2 VCAN	3.00e-05	126	131	7	PF00008
Domain	PKD	PKD1L1 TMEM130 SORCS3	5.34e-05	11	131	3	PS50093
Domain	PKD_dom	PKD1L1 TMEM130 SORCS3	5.34e-05	11	131	3	IPR000601
Domain	-	PKD1L1 TMEM130 SORCS3	5.34e-05	11	131	3	2.60.40.670
Domain	EGF_Ca-bd_CS	FAT3 F9 CRB1 FAT1 VCAN ADGRE1	6.22e-05	97	131	6	IPR018097
Domain	EGF_CA	FAT3 F9 CRB1 FAT1 VCAN ADGRE1	6.97e-05	99	131	6	PS01187
Domain	GPS	ADGRB1 ADGRG4 CELSR1 ADGRE1	9.11e-05	34	131	4	SM00303
Domain	GPS	ADGRB1 ADGRG4 CELSR1 ADGRE1	1.02e-04	35	131	4	PF01825
Domain	CAC1F_C	CACNA1C CACNA1D	1.46e-04	3	131	2	IPR031688
Domain	CAC1F_C	CACNA1C CACNA1D	1.46e-04	3	131	2	PF16885
Domain	CTF_NFI	NFIA NFIC	2.90e-04	4	131	2	PF00859
Domain	CTF_NFI_1	NFIA NFIC	2.90e-04	4	131	2	PS00349
Domain	CTF_NFI_2	NFIA NFIC	2.90e-04	4	131	2	PS51080
Domain	CTF/NFI_DNA-bd-dom	NFIA NFIC	2.90e-04	4	131	2	IPR020604
Domain	VDCC_L_a1su	CACNA1C CACNA1D	2.90e-04	4	131	2	IPR005446
Domain	NfI_DNAbd_pre-N	NFIA NFIC	2.90e-04	4	131	2	PF10524
Domain	CTF/NFI	NFIA NFIC	2.90e-04	4	131	2	IPR000647
Domain	CTF/NFI_DNA-bd_N	NFIA NFIC	2.90e-04	4	131	2	IPR019548
Domain	CTF/NFI_DNA-bd_CS	NFIA NFIC	2.90e-04	4	131	2	IPR019739
Domain	VWC_out	FRAS1 MUC19 FCGBP	3.01e-04	19	131	3	SM00215
Domain	7tm_2	ADGRB1 ADGRG4 CELSR1 ADGRE1	4.15e-04	50	131	4	PF00002
Domain	G_PROTEIN_RECEP_F2_2	ADGRB1 ADGRG4 CELSR1 ADGRE1	4.15e-04	50	131	4	PS00650
Domain	Autophagy-rel_C	ATG2B VPS13A	4.82e-04	5	131	2	IPR015412
Domain	ATG_C	ATG2B VPS13A	4.82e-04	5	131	2	PF09333
Domain	Nlgn	NLGN1 NLGN2	4.82e-04	5	131	2	IPR000460
Domain	GPCR_2_secretin-like	ADGRB1 ADGRG4 CELSR1 ADGRE1	8.32e-04	60	131	4	IPR000832
Domain	GPCR_2-like	ADGRB1 ADGRG4 CELSR1 ADGRE1	8.32e-04	60	131	4	IPR017981
Domain	G_PROTEIN_RECEP_F2_4	ADGRB1 ADGRG4 CELSR1 ADGRE1	8.85e-04	61	131	4	PS50261
Domain	PKD	PKD1L1 SORCS3	1.00e-03	7	131	2	PF00801
Domain	Ca_chan_IQ	CACNA1C CACNA1D	1.00e-03	7	131	2	SM01062
Domain	Ca_chan_IQ	CACNA1C CACNA1D	1.00e-03	7	131	2	PF08763
Domain	VDCC_a1su_IQ	CACNA1C CACNA1D	1.00e-03	7	131	2	IPR014873
Domain	GPHH	CACNA1C CACNA1D	1.00e-03	7	131	2	PF16905
Domain	GPHH_dom	CACNA1C CACNA1D	1.00e-03	7	131	2	IPR031649
Domain	Chorein_N	ATG2B VPS13A	1.33e-03	8	131	2	PF12624
Domain	VPS13_N	ATG2B VPS13A	1.33e-03	8	131	2	IPR026854
Domain	Sialidases	RELN SORCS3	1.70e-03	9	131	2	IPR011040
Domain	Rap_GAP	RALGAPA1 RAP1GAP	2.12e-03	10	131	2	PF02145
Domain	VDCCAlpha1	CACNA1C CACNA1D	2.12e-03	10	131	2	IPR002077
Domain	VWC	FRAS1 MUC19 FCGBP	2.38e-03	38	131	3	SM00214
Domain	Rap_GAP_dom	RALGAPA1 RAP1GAP	2.58e-03	11	131	2	IPR000331
Domain	GAIN_dom_N	ADGRB1 CELSR1	2.58e-03	11	131	2	IPR032471
Domain	RAPGAP	RALGAPA1 RAP1GAP	2.58e-03	11	131	2	PS50085
Domain	GAIN	ADGRB1 CELSR1	2.58e-03	11	131	2	PF16489
Domain	GPCR_2_extracellular_dom	ADGRB1 ADGRG4 CELSR1	2.76e-03	40	131	3	IPR001879
Domain	G_PROTEIN_RECEP_F2_1	ADGRB1 ADGRG4 CELSR1	2.76e-03	40	131	3	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRB1 ADGRG4 CELSR1	2.76e-03	40	131	3	PS50227
Domain	MAD_homology1_Dwarfin-type	NFIA NFIC	3.08e-03	12	131	2	IPR003619
Domain	DWA	NFIA NFIC	3.08e-03	12	131	2	SM00523
Domain	C8	MUC19 FCGBP	3.08e-03	12	131	2	PF08742
Domain	TIL	MUC19 FCGBP	3.08e-03	12	131	2	PF01826
Domain	MH1	NFIA NFIC	3.08e-03	12	131	2	PF03165
Domain	VWF_dom	FRAS1 MUC19 FCGBP	3.17e-03	42	131	3	IPR001007
Domain	FN3_dom	IL10RA SDK2 CMYA5 CRLF3 COL14A1 MERTK	3.59e-03	209	131	6	IPR003961
Domain	Carboxylesterase_B_CS	NLGN1 NLGN2	3.62e-03	13	131	2	IPR019819
Domain	Unchr_dom_Cys-rich	MUC19 FCGBP	3.62e-03	13	131	2	IPR014853
Domain	C8	MUC19 FCGBP	3.62e-03	13	131	2	SM00832
Domain	CARBOXYLESTERASE_B_2	NLGN1 NLGN2	4.20e-03	14	131	2	PS00941
Domain	TIL_dom	MUC19 FCGBP	4.20e-03	14	131	2	IPR002919
Domain	COesterase	NLGN1 NLGN2	4.20e-03	14	131	2	PF00135
Domain	CarbesteraseB	NLGN1 NLGN2	4.20e-03	14	131	2	IPR002018
Domain	Growth_fac_rcpt_	FRAS1 CRB1 FAT1 CELSR1 ADGRE1	4.88e-03	156	131	5	IPR009030
Domain	WD40_repeat_dom	IFT140 SCAP LLGL1 TENM3 WDR87 UTP4 WDR90	5.00e-03	297	131	7	IPR017986
Domain	VWF_type-D	MUC19 FCGBP	5.49e-03	16	131	2	IPR001846
Domain	VWFD	MUC19 FCGBP	5.49e-03	16	131	2	PS51233
Domain	VWD	MUC19 FCGBP	5.49e-03	16	131	2	SM00216
Domain	VWD	MUC19 FCGBP	5.49e-03	16	131	2	PF00094
Domain	Quinoprotein_ADH-like_supfam	WDR87 UTP4 WDR90	6.12e-03	53	131	3	IPR011047
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	DCHS2 FAT3 FAT1 FAT2	7.53e-09	7	135	4	16059920
Pubmed	Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes.	FAT3 FAT1 FAT2	5.72e-08	3	135	3	15744052
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	FRAS1 SDK2 PHRF1 SYBU NLGN1 TENM3 NLGN2	1.65e-07	103	135	7	10819331
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	CLSTN3 SDK2 CDHR1 FAT3 TENM3 CDH4	1.56e-06	91	135	6	28558017
Pubmed	International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.	ADGRB1 ADGRG4 CELSR1 ADGRE1	8.14e-06	33	135	4	25713288
Pubmed	Loss of both phospholipid and triglyceride transfer activities of microsomal triglyceride transfer protein in abetalipoproteinemia.	P4HB MTTP	1.50e-05	2	135	2	23475612
Pubmed	Different roles attributed to Cav1 channel subtypes in spontaneous action potential firing and fine tuning of exocytosis in mouse chromaffin cells.	CACNA1C CACNA1D	1.50e-05	2	135	2	21054386
Pubmed	Identification and characterization of versican/PG-M aggregates in cartilage.	ACAN VCAN	1.50e-05	2	135	2	16648631
Pubmed	Cleavage of the carboxyl tail from the G3 domain of aggrecan but not versican and identification of the amino acids involved in the degradation.	ACAN VCAN	1.50e-05	2	135	2	11932252
Pubmed	An improved targeted cAMP sensor to study the regulation of adenylyl cyclase 8 by Ca2+ entry through voltage-gated channels.	CACNA1C CACNA1D	1.50e-05	2	135	2	24086669
Pubmed	Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.	CACNA1C CACNA1D	1.50e-05	2	135	2	26049024
Pubmed	Phospholipid transfer activity of microsomal triacylglycerol transfer protein is sufficient for the assembly and secretion of apolipoprotein B lipoproteins.	P4HB MTTP	1.50e-05	2	135	2	16478722
Pubmed	Genetic polymorphisms of L-type calcium channel alpha1C and alpha1D subunit genes are associated with sensitivity to the antihypertensive effects of L-type dihydropyridine calcium-channel blockers.	CACNA1C CACNA1D	1.50e-05	2	135	2	19225208
Pubmed	Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB.	CACNA1C CACNA1D	1.50e-05	2	135	2	16706838
Pubmed	Temperature-sensitive Cav1.2 calcium channels support intrinsic firing of pyramidal neurons and provide a target for the treatment of febrile seizures.	CACNA1C CACNA1D	1.50e-05	2	135	2	23761887
Pubmed	Non-voltage-gated L-type Ca2+ channels in human T cells: pharmacology and molecular characterization of the major alpha pore-forming and auxiliary beta-subunits.	CACNA1C CACNA1D	1.50e-05	2	135	2	14981074
Pubmed	CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum.	CACNA1C CACNA1D	1.50e-05	2	135	2	25292336
Pubmed	Ca(v)1.3 channels produce persistent calcium sparklets, but Ca(v)1.2 channels are responsible for sparklets in mouse arterial smooth muscle.	CACNA1C CACNA1D	1.50e-05	2	135	2	17526649
Pubmed	Ligand-activated signal transduction in the 2-cell embryo.	CACNA1C CACNA1D	1.50e-05	2	135	2	12606379
Pubmed	Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators.	CACNA1C CACNA1D	1.50e-05	2	135	2	24941892
Pubmed	Equal sensitivity of Cav1.2 and Cav1.3 channels to the opposing modulations of PKA and PKG in mouse chromaffin cells.	CACNA1C CACNA1D	1.50e-05	2	135	2	22826131
Pubmed	Transcriptional regulation of L-type calcium channel subtypes Cav1.2 and Cav1.3 by nicotine and their potential role in nicotine sensitization.	CACNA1C CACNA1D	1.50e-05	2	135	2	24470632
Pubmed	Neuroligin-2 deletion selectively decreases inhibitory synaptic transmission originating from fast-spiking but not from somatostatin-positive interneurons.	NLGN1 NLGN2	1.50e-05	2	135	2	19889999
Pubmed	Cav1.2 and Cav1.3 L-type calcium channels operate in a similar voltage range but show different coupling to Ca(2+)-dependent conductances in hippocampal neurons.	CACNA1C CACNA1D	1.50e-05	2	135	2	24760982
Pubmed	Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein.	P4HB MTTP	1.50e-05	2	135	2	8111381
Pubmed	Deletion of the L-type calcium channel Ca(V) 1.3 but not Ca(V) 1.2 results in a diminished sAHP in mouse CA1 pyramidal neurons.	CACNA1C CACNA1D	1.50e-05	2	135	2	20014384
Pubmed	Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons.	NLGN1 NLGN2	1.50e-05	2	135	2	10892652
Pubmed	Role of putative voltage-sensor countercharge D4 in regulating gating properties of CaV1.2 and CaV1.3 calcium channels.	CACNA1C CACNA1D	1.50e-05	2	135	2	30001160
Pubmed	Rescue and worsening of congenital heart block-associated electrocardiographic abnormalities in two transgenic mice.	CACNA1C CACNA1D	1.50e-05	2	135	2	21352396
Pubmed	Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells.	CACNA1C CACNA1D	1.50e-05	2	135	2	17409250
Pubmed	Neuronal L-type calcium channels open quickly and are inhibited slowly.	CACNA1C CACNA1D	1.50e-05	2	135	2	16267232
Pubmed	The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function.	CACNA1C CACNA1D	1.50e-05	2	135	2	24996399
Pubmed	CYP2C8 and CYP2E1 genetic variants increase risk of tuberculosis in northwest Chinese Han population.	CYP2C8 CYP2E1	1.50e-05	2	135	2	34371160
Pubmed	NLGN1 and NLGN2 in the prefrontal cortex: their role in memory consolidation and strengthening.	NLGN1 NLGN2	1.50e-05	2	135	2	29278843
Pubmed	MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression.	SAV1 MERTK	1.50e-05	2	135	2	30944303
Pubmed	Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer.	VCAN SDC1	1.50e-05	2	135	2	20204274
Pubmed	Genetic, cellular, and functional evidence for Ca2+ inflow through Cav1.2 and Cav1.3 channels in murine spiral ganglion neurons.	CACNA1C CACNA1D	1.50e-05	2	135	2	24849370
Pubmed	Divide and conquer: an L-type voltage-gated calcium channel subtype finds a role in conditioned fear.	CACNA1C CACNA1D	1.50e-05	2	135	2	17015854
Pubmed	Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area.	CACNA1C CACNA1D	1.50e-05	2	135	2	24848473
Pubmed	WDR87 interacts with CFAP47 protein in the middle piece of spermatozoa flagella to participate in sperm tail assembly.	CFAP47 WDR87	1.50e-05	2	135	2	36571501
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRAS1 CLSTN3 NLGN1 ADCY6 FOCAD TENM3 BAZ2A NAV3 BOD1L1	3.22e-05	407	135	9	12693553
Pubmed	Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss.	KCNV2 CDHR1 RBP3 RB1CC1 CRB1 NSDHL MERTK	3.70e-05	233	135	7	32290105
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC20	4.47e-05	18	135	3	18834073
Pubmed	Comparison of expression patterns between CREB family transcription factor OASIS and proteoglycan core protein genes during murine tooth development.	ACAN VCAN SDC1	4.47e-05	18	135	3	12684764
Pubmed	Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.	DCHS2 FAT3 FAT2	4.47e-05	18	135	3	33108146
Pubmed	Developmental expression and subcellular distribution of synaptotagmin 11 in rat hippocampus.	NLGN1 NLGN2	4.48e-05	3	135	2	22960622
Pubmed	Unique versus Redundant Functions of Neuroligin Genes in Shaping Excitatory and Inhibitory Synapse Properties.	NLGN1 NLGN2	4.48e-05	3	135	2	28607166
Pubmed	Link protein has greater affinity for versican than aggrecan.	ACAN VCAN	4.48e-05	3	135	2	14724283
Pubmed	Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.	ACAN VCAN	4.48e-05	3	135	2	19669783
Pubmed	Expression and purification of functionally active hyaluronan-binding domains from human cartilage link protein, aggrecan and versican: formation of ternary complexes with defined hyaluronan oligosaccharides.	ACAN VCAN	4.48e-05	3	135	2	15590670
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC20	4.48e-05	3	135	2	30236127
Pubmed	Impairment of hippocampal gamma-frequency oscillations in vitro in mice overexpressing human amyloid precursor protein (APP).	CACNA1C CACNA1D	4.48e-05	3	135	2	17767505
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC20	4.48e-05	3	135	2	26770020
Pubmed	Molecular diversity of L-type calcium channels. Evidence for alternative splicing of the transcripts of three non-allelic genes.	CACNA1C CACNA1D	4.48e-05	3	135	2	2173707
Pubmed	The p53 tumor suppressor gene is regulated in vivo by nuclear factor 1-C2 in the mouse mammary gland during pregnancy.	NFIA NFIC	4.48e-05	3	135	2	12955085
Pubmed	Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits.	NLGN1 NLGN2	4.48e-05	3	135	2	29100073
Pubmed	Methodologies for analysis of patterning in the mouse RPE sheet.	RBP3 CRB1	4.48e-05	3	135	2	25593512
Pubmed	Synaptic Adhesion Molecules Regulate the Integration of New Granule Neurons in the Postnatal Mouse Hippocampus and their Impact on Spatial Memory.	NLGN1 NLGN2	4.48e-05	3	135	2	27473321
Pubmed	G protein-gated IKACh channels as therapeutic targets for treatment of sick sinus syndrome and heart block.	CACNA1C CACNA1D	4.48e-05	3	135	2	26831068
Pubmed	The zebrafish grime mutant uncovers an evolutionarily conserved role for Tmem161b in the control of cardiac rhythm.	CACNA1C KCNV2	4.48e-05	3	135	2	33597309
Pubmed	Neuroligins Sculpt Cerebellar Purkinje-Cell Circuits by Differential Control of Distinct Classes of Synapses.	NLGN1 NLGN2	4.48e-05	3	135	2	26291161
Pubmed	Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican.	ACAN VCAN	4.48e-05	3	135	2	10400671
Pubmed	Truncation of murine CaV1.2 at Asp 1904 increases CaV1.3 expression in embryonic atrial cardiomyocytes.	CACNA1C CACNA1D	4.48e-05	3	135	2	23338940
Pubmed	Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses.	NLGN1 NLGN2	4.48e-05	3	135	2	17897391
Pubmed	Neuroligins determine synapse maturation and function.	NLGN1 NLGN2	4.48e-05	3	135	2	16982420
Pubmed	Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC.	CACNA1C ITIH3	4.48e-05	3	135	2	22614287
Pubmed	Genome-wide association study of major recurrent depression in the U.K. population.	NLGN1 VCAN	4.48e-05	3	135	2	20516156
Pubmed	The intracellular II-III loops of Cav1.2 and Cav1.3 uncouple L-type voltage-gated Ca2+ channels from glucagon-like peptide-1 potentiation of insulin secretion in INS-1 cells via displacement from lipid rafts.	CACNA1C CACNA1D	4.48e-05	3	135	2	19351867
Pubmed	Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth.	CACNA1C CACNA1D	4.48e-05	3	135	2	21832054
Pubmed	Distinct interaction of versican/PG-M with hyaluronan and link protein.	ACAN VCAN	4.48e-05	3	135	2	12888576
Pubmed	Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function.	P4HB MTTP	4.48e-05	3	135	2	26224785
Pubmed	CREB binding protein coordinates the function of multiple transcription factors including nuclear factor I to regulate phosphoenolpyruvate carboxykinase (GTP) gene transcription.	NFIA NFIC	4.48e-05	3	135	2	10085123
Pubmed	Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels.	CACNA1C CACNA1D	4.48e-05	3	135	2	17289261
Pubmed	Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure.	CACNA1C CACNA1D	4.48e-05	3	135	2	23973784
Pubmed	In situ hybridization and immunohistochemistry of versican, aggrecan and link protein, and histochemistry of hyaluronan in the developing mouse limb bud cartilage.	ACAN VCAN	4.48e-05	3	135	2	14620382
Pubmed	MicroRNA-1976 regulates degeneration of the sinoatrial node by targeting Cav1.2 and Cav1.3 ion channels.	CACNA1C CACNA1D	4.48e-05	3	135	2	31302118
Pubmed	Distinct localization and modulation of Cav1.2 and Cav1.3 L-type Ca2+ channels in mouse sinoatrial node.	CACNA1C CACNA1D	4.48e-05	3	135	2	23045342
Pubmed	Conditional ablation of neuroligin-1 in CA1 pyramidal neurons blocks LTP by a cell-autonomous NMDA receptor-independent mechanism.	NLGN1 NLGN2	4.48e-05	3	135	2	27217145
Pubmed	Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.	CACNA1C CACNA1D	4.48e-05	3	135	2	24934288
Pubmed	Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection.	ACAN VCAN	4.48e-05	3	135	2	29515038
Pubmed	Determination of cleavage site of Reelin between its sixth and seventh repeat and contribution of meprin metalloproteases to the cleavage.	RELN MEP1B	4.48e-05	3	135	2	26491063
Pubmed	Conditional hepatocyte ablation of PDIA1 uncovers indispensable roles in both APOB and MTTP folding to support VLDL secretion.	P4HB MTTP	4.48e-05	3	135	2	38211723
Pubmed	PRMT7 methylates and suppresses GLI2 binding to SUFU thereby promoting its activation.	PRMT7 SUFU	4.48e-05	3	135	2	31000813
Pubmed	Structure of the N terminus of cadherin 23 reveals a new adhesion mechanism for a subset of cadherin superfamily members.	CDHR1 PCDH15	4.48e-05	3	135	2	20498078
Pubmed	Activity-dependent validation of excitatory versus inhibitory synapses by neuroligin-1 versus neuroligin-2.	NLGN1 NLGN2	4.48e-05	3	135	2	17582332
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	IFT140 FRAS1 PKD1L1 ACAN SUFU	4.58e-05	100	135	5	25807483
Pubmed	Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins.	CLSTN3 ADGRB1 NLGN1 NLGN2	5.09e-05	52	135	4	24613359
Pubmed	A mouse knockout library for secreted and transmembrane proteins.	LAYN PCDHB13 PCDHB8 MUC16 HEPACAM2 TMEM130 CRLF3 FCRL5 MUC20	8.24e-05	460	135	9	20562862
Pubmed	Autism-related deficits via dysregulated eIF4E-dependent translational control.	NLGN1 NLGN2	8.93e-05	4	135	2	23172145
Pubmed	[Association of single nucleotide polymorphisms of cytochrome P450 gene with susceptibility to gout in ethnic Han males from coastal regions of Shandong province].	CYP2C8 CYP2E1	8.93e-05	4	135	2	26252103
Pubmed	Beta-adrenergic-regulated phosphorylation of the skeletal muscle Ca(V)1.1 channel in the fight-or-flight response.	CACNA1C CACNA1D	8.93e-05	4	135	2	20937870
Pubmed	ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1.	ACAN SDC1	8.93e-05	4	135	2	14701864
Pubmed	Novel missense MTTP gene mutations causing abetalipoproteinemia.	P4HB MTTP	8.93e-05	4	135	2	25108285
Pubmed	Fast Ca2+ Transients of Inner Hair Cells Arise Coupled and Uncoupled to Ca2+ Waves of Inner Supporting Cells in the Developing Mouse Cochlea.	CACNA1D P2RX3	8.93e-05	4	135	2	30104958
Pubmed	Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development.	NFIA NFIC	8.93e-05	4	135	2	9056636
Pubmed	Neuroligin 1, 2, and 3 Regulation at the Synapse: FMRP-Dependent Translation and Activity-Induced Proteolytic Cleavage.	NLGN1 NLGN2	8.93e-05	4	135	2	30056576
Pubmed	Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations.	CYP2C8 CYP2E1	8.93e-05	4	135	2	24988984
Pubmed	Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma.	CYP2C8 CYP2E1	8.93e-05	4	135	2	17373732
Pubmed	Nuclear factor one transcription factors as epigenetic regulators in cancer.	NFIA NFIC	8.93e-05	4	135	2	28076901
Pubmed	Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2.	CACNA1C CACNA1D	8.93e-05	4	135	2	17110593
Interaction	NUP210P1 interactions	IFT140 MAN2C1 FAT3 CELSR1 VPS13A	7.82e-06	42	132	5	int:NUP210P1
GeneFamily	Cadherin related	DCHS2 CLSTN3 CDHR1 FAT3 FAT1 FAT2 PCDH15	9.48e-13	17	88	7	24
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC22 MUC20	2.94e-06	21	88	4	648
GeneFamily	Fibronectin type III domain containing	SDK2 CMYA5 CRLF3 PTPRQ COL14A1 MERTK	1.30e-04	160	88	6	555
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN VCAN	1.40e-04	4	88	2	574
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	LAYN ACAN VCAN	1.04e-03	41	88	3	1298
GeneFamily	WD repeat domain containing	IFT140 SCAP LLGL1 WDR87 UTP4 WDR90	1.76e-03	262	88	6	362
Coexpression	PRC1_BMI_UP.V1_DN	SDK2 RBPJL MFSD6 L2HGDH ECPAS NPFFR1 P2RX3 DNMT3L	5.60e-06	187	134	8	M2730
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2A	CFAP47 CDHR1 FAT3 NLGN1 SLC1A4 CRB1 FAT1 CELSR1 FAT2 LLGL1 NFIA MTTP CTNND2	1.31e-05	600	134	13	M39055
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000	CACNA1C FRAS1 CLSTN3 SDK2 RAP1GAP CYP2E1 FAT3 MFSD6 CAPN6 PCDHB8 NLGN1 DNAAF9 BDH1 NFIA NFIC PCDH15 NAV3 COL14A1 NMBR	7.64e-06	967	131	19	Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	CACNA1C SMAP1 SDK2 FAT3 CAPN6 ATG2B PCDHB8 NLGN1 HSPA12B SLC1A4 IARS2 FAT1 SNAP91 NFIA NFIC VCAN PTPRQ NAV3 CKAP2L COL14A1 CDH4	9.18e-06	1166	131	21	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500	CACNA1C CLSTN3 SDK2 CYP2E1 MFSD6 CAPN6 PCDHB8 NLGN1 NFIA PCDH15 NAV3 COL14A1	4.24e-05	479	131	12	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 FAT3 TENM3 VCAN PCDH15 SORCS3 COL14A1	7.31e-09	191	135	9	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C CACNA1D FAT3 TENM3 VCAN PCDH15 NAV3 COL14A1 HMGCLL1	1.09e-08	200	135	9	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 FAT3 PCDH15 NAV3 SORCS3 COL14A1	8.07e-08	180	135	8	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 FAT3 PCDH15 NAV3 SORCS3 COL14A1	8.07e-08	180	135	8	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	RAP1GAP RBPJL GPRC5A FAT2 SLCO4C1 CTNND2 SDC1 MUC20	9.16e-08	183	135	8	23e55f88a802a9299d2773f9394970e86e8bbfaa
ToppCell	PND07-28-samps-Epithelial-Alveolar_epithelial-AT2\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	RAP1GAP RBPJL GPRC5A FAT2 SLCO4C1 CTNND2 SDC1 MUC20	9.16e-08	183	135	8	0a69e22750dd8b66ab988cf36d0dd2b59e2f7d26
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RELN FAT3 FAT1 PTPRQ PCDH15 PKHD1 NAV3	9.56e-08	184	135	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RELN FAT3 FAT1 PTPRQ PCDH15 PKHD1 NAV3	9.56e-08	184	135	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 RELN FAT3 FAT1 PTPRQ PCDH15 PKHD1 NAV3	9.56e-08	184	135	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CACNA1C FRAS1 RELN NLGN1 NFIA NAV3 SORCS3 COL14A1	1.04e-07	186	135	8	8915436d09775f2828a7678af203b1082b36e21c
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	CACNA1C CACNA1D FRAS1 FAT3 TENM3 PCDH15 NAV3 HMGCLL1	1.08e-07	187	135	8	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 TENM3 VCAN PCDH15 SORCS3 COL14A1	1.22e-07	190	135	8	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C CACNA1D FRAS1 FAT3 TENM3 PCDH15 NAV3 HMGCLL1	1.27e-07	191	135	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CACNA1C CACNA1D FRAS1 FAT3 TENM3 PCDH15 NAV3 HMGCLL1	1.33e-07	192	135	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 FAT3 TENM3 PCDH15 SORCS3 COL14A1	1.33e-07	192	135	8	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 FAT3 TENM3 PCDH15 SORCS3 COL14A1	1.33e-07	192	135	8	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 FAT3 TENM3 PCDH15 SORCS3 COL14A1	1.33e-07	192	135	8	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 FAT3 TENM3 PCDH15 SORCS3 COL14A1	1.43e-07	194	135	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 FAT3 TENM3 PCDH15 SORCS3 COL14A1	1.43e-07	194	135	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	CACNA1C CACNA1D FRAS1 FAT3 TENM3 PCDH15 NAV3 HMGCLL1	1.49e-07	195	135	8	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA1C CACNA1D FRAS1 FAT3 NLGN1 NFIA VCAN COL14A1	1.61e-07	197	135	8	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1C CACNA1D FAT3 NLGN1 NFIA VCAN COL14A1 CDH4	1.61e-07	197	135	8	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1C CACNA1D FAT3 NLGN1 TENM3 NFIA VCAN COL14A1	1.68e-07	198	135	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C CACNA1D FRAS1 FAT3 TENM3 PCDH15 NAV3 HMGCLL1	1.81e-07	200	135	8	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CACNA1C CACNA1D FRAS1 SDK2 FAT3 PCDH15 NAV3 HMGCLL1	1.81e-07	200	135	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CACNA1C CACNA1D FRAS1 SDK2 FAT3 PCDH15 NAV3 HMGCLL1	1.81e-07	200	135	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C CACNA1D FAT3 TENM3 VCAN NAV3 COL14A1 HMGCLL1	1.81e-07	200	135	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C CACNA1D FRAS1 FAT3 TENM3 PCDH15 NAV3 HMGCLL1	1.81e-07	200	135	8	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CACNA1C CACNA1D FRAS1 SDK2 FAT3 PCDH15 NAV3 HMGCLL1	1.81e-07	200	135	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 KCNV2 FAT3 MUC19 CRB1 PTPRQ PKHD1	5.96e-07	160	135	7	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 KCNV2 FAT3 MUC19 CRB1 PTPRQ PKHD1	5.96e-07	160	135	7	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1C FRAS1 FAT3 SNAP91 PTPRQ PCDH15 PKHD1	6.48e-07	162	135	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SDK2 PCDHB13 MUC19 BEST3 HEPACAM2 TENM3 NAV3	8.96e-07	170	135	7	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDHR1 MUC16 GPRC5A PITPNM1 FAT2 LLGL1 SDC1	1.05e-06	174	135	7	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	COVID-19-kidney-Epi_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DCHS2 RELN NLGN1 TMEM130 FAT1 TENM3 PKHD1	1.22e-06	178	135	7	544379f5a6145429762258d426b876bb36c112f5
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP RBPJL NLGN1 ACAN VCAN PCDH15 NAV3	1.31e-06	180	135	7	fa819df81fca95c2cc602fede635cb03e3f35fad
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP RBPJL NLGN1 ACAN VCAN PCDH15 NAV3	1.31e-06	180	135	7	907cd510fd2e21532ce04ba687e8894f7af71f27
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 RELN TMEM130 FAT1 TENM3 VCAN NAV3	1.36e-06	181	135	7	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 RELN TMEM130 FAT1 TENM3 VCAN NAV3	1.36e-06	181	135	7	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	droplet-Lung-LUNG-1m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP RBPJL GPRC5A CELSR1 SLCO4C1 SDC1 HMGCLL1	1.41e-06	182	135	7	c1e0be27064e14043b78ae501b02d4e9542267a3
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Alveolar_Epithelial_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP RBPJL GPRC5A CELSR1 SLCO4C1 SDC1 HMGCLL1	1.41e-06	182	135	7	3c9b4869d357884ae4bcd22a9872faf83a5cfc6d
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DCHS2 P2RX3 TENM3 VCAN TRIM62 NMBR	1.80e-06	120	135	6	a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 TENM3 PCDH15 SORCS3 COL14A1	1.82e-06	189	135	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 TENM3 PCDH15 SORCS3 COL14A1	1.82e-06	189	135	7	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CACNA1D FRAS1 FAT3 CMYA5 PCDH15 COL14A1 HMGCLL1	1.82e-06	189	135	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYP2C8 CYP2E1 BEST3 HEPACAM2 F9 ITIH3 MTTP	1.82e-06	189	135	7	7899af78b273d9c7f029d52f7e0cf6df4da41f5e
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 FAT3 PCDH15 SORCS3 COL14A1	1.82e-06	189	135	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CYP2C8 CYP2E1 BEST3 HEPACAM2 F9 ITIH3 MTTP	1.88e-06	190	135	7	a34293601aefe5fb5c400c14091294b9ddaa195b
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	CACNA1C CACNA1D FAT3 TENM3 VCAN PCDH15 NAV3	1.88e-06	190	135	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 TENM3 PCDH15 SORCS3 COL14A1	2.02e-06	192	135	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 TENM3 PCDH15 SORCS3 COL14A1	2.02e-06	192	135	7	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RAP1GAP RBPJL GPRC5A CELSR1 SLCO4C1 SDC1 MUC20	2.02e-06	192	135	7	13e4b17d7a592604140777aca235f795df6b3f91
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 TENM3 PCDH15 SORCS3 COL14A1	2.02e-06	192	135	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 TENM3 PCDH15 SORCS3 COL14A1	2.02e-06	192	135	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D SDK2 TENM3 PCDH15 SORCS3 COL14A1	2.02e-06	192	135	7	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_II_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RAP1GAP RBPJL GPRC5A CELSR1 SLCO4C1 SDC1 MUC20	2.02e-06	192	135	7	6244541688f85917018a057aa0b3e5972934dfbc
ToppCell	facs-Lung-nan-3m-Epithelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP RBPJL GPRC5A FAT1 CELSR1 SLCO4C1 SDC1	2.02e-06	192	135	7	cca2d0fedfbd946c54d6f4fc45887117c8dae58a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 TENM3 PCDH15 SORCS3 COL14A1	2.09e-06	193	135	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	CACNA1C CACNA1D FRAS1 SDK2 FAT3 PCDH15 HMGCLL1	2.09e-06	193	135	7	acad568621ed677031797b8c2e34dafea798d681
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 TENM3 PCDH15 SORCS3 COL14A1	2.16e-06	194	135	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1D FAT3 NLGN1 NFIA VCAN COL14A1 CDH4	2.24e-06	195	135	7	1cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 PCDH15 COL14A1 NLGN2	2.28e-06	125	135	6	b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FRAS1 KCNV2 GPRC5A FAT1 CELSR1 FAT2 SDC1	2.31e-06	196	135	7	c5adab88140a465698abcbedc6505a43cae7bfd1
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CACNA1D FAT3 NLGN1 NFIA VCAN COL14A1 CDH4	2.39e-06	197	135	7	31a1852911bda38543916585fda34255fd62a134
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA1C CACNA1D FAT3 TENM3 VCAN NAV3 COL14A1	2.47e-06	198	135	7	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CACNA1C CACNA1D FAT3 NLGN1 NFIA VCAN COL14A1	2.47e-06	198	135	7	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	CACNA1C CACNA1D FRAS1 TENM3 VCAN NAV3 COL14A1	2.47e-06	198	135	7	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 RELN LAYN TMEM130 FAT1 TENM3 VCAN	2.56e-06	199	135	7	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DCHS2 RELN LAYN TMEM130 FAT1 TENM3 VCAN	2.56e-06	199	135	7	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CLSTN3 SDK2 TENM3 VCAN PCDH15 SORCS3 COL14A1	2.56e-06	199	135	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C CACNA1D FAT3 TENM3 VCAN NAV3 COL14A1	2.64e-06	200	135	7	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 CRB1 SNAP91 PTPRQ PCDH15 PKHD1	5.39e-06	145	135	6	96712c68ab759d7ade0d912581a1a7c25dc6def8
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADGRB1 CMYA5 ACAN VCAN PCDH15 SORCS3	7.90e-06	155	135	6	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN FAT3 PCDH15 NAV3 CTNND2 CDH4	9.14e-06	159	135	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OSTN NLGN1 TENM3 VCAN CKAP2L COL14A1	1.17e-05	166	135	6	49103b75c3e08656c5774f56fd00d7bd53eefcfb
ToppCell	Adult-Epithelial-lung_goblet_cell-D122\|Adult / Lineage, Cell type, age group and donor	RAP1GAP SYBU BDH1 TMEM130 CELSR1 FCGBP	1.21e-05	167	135	6	6efbb2ef6adc8da5dd67210969f825f5cc8ed022
ToppCell	COVID-19-kidney-PEC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FRAS1 NLGN1 TMEM130 FAT1 TENM3 PKHD1	1.25e-05	168	135	6	a086c306be430adf0632ba53e98cd8014d2de330
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 FAT3 NLGN1 PCDH15 PKHD1 SORCS3	1.29e-05	169	135	6	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL10RA GPRC5A PITPNM1 FCRL5 HMGCLL1 CCDC158	1.43e-05	172	135	6	3f784aed340b50ddbec3f7dc0a5279180d38a2bb
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 MUC19 HEPACAM2 PTPRQ PKHD1 FCRL5	1.58e-05	175	135	6	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	AT1_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	FRAS1 GPRC5A RANBP17 CTNND2 SDC1 HMGCLL1	1.63e-05	176	135	6	458720776b0151cd55acc352d509599cb62f0ca8
ToppCell	COVID-19-kidney-PCT-S3-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CYP2C8 CYP2E1 TPPP2 F9 ITIH3 MTTP	1.63e-05	176	135	6	b6497324e3e52f514ce556a3fa0c3011c45dcc7b
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RAP1GAP MFSD6 ANKLE1 RANBP17 FCGBP TMEM192	1.68e-05	177	135	6	e1e45956887371b1c18f1eb479dd930031497520
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 NLGN1 GPRC5A CELSR1 PTPRQ PKHD1	1.68e-05	177	135	6	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SDK2 CAPN6 BDH1 TENM3 ACAN NMBR	1.74e-05	178	135	6	8591a40fced747ac16b3e8ebc7a22dfb3ad76da2
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1C CACNA1D FRAS1 SDK2 BEST3 CRB1	1.74e-05	178	135	6	fcbbcc44271515de1969b4732b6441c012693d5f
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	DCHS2 MUC16 SYBU HEPACAM2 CELSR1 FCGBP	1.79e-05	179	135	6	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FRAS1 PPP1R13B GPRC5A NPFFR1 CELSR1 SDC1	1.79e-05	179	135	6	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 NLGN1 GPRC5A CELSR1 PTPRQ PKHD1	1.79e-05	179	135	6	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFAP47 GPRC5A TENM3 SORCS3 CDH4 DNMT3L	1.85e-05	180	135	6	35c73670da90cb6924e822a2426d13a675685f09
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CACNA1D FAT3 PCDH15 SORCS3 COL14A1	1.91e-05	181	135	6	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FRAS1 NLGN1 GPRC5A CELSR1 PTPRQ PKHD1	1.91e-05	181	135	6	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1C CACNA1D FRAS1 FAT3 PCDH15 HMGCLL1	1.91e-05	181	135	6	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CAPN6 CMYA5 NFIA VCAN NAV3 COL14A1	1.97e-05	182	135	6	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	NLGN1 FAT1 SLCO4C1 NFIA VPS13A PKHD1	2.09e-05	184	135	6	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RAP1GAP RBPJL CELSR1 SLCO4C1 SDC1 HMGCLL1	2.09e-05	184	135	6	24cbe9f2461ea920954e44bf3b2c2a6a5d4debfb
ToppCell	droplet-Lung-1m-Epithelial-alveolar_epithelial-type_II_pneumocyte\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RAP1GAP RBPJL CELSR1 SLCO4C1 SDC1 HMGCLL1	2.09e-05	184	135	6	98079fd048a63b51bbdf3833b6f15bf0ae99ea90
ToppCell	facs-Lung-EPCAM-18m-Epithelial-type_II_pneumocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP RBPJL GPRC5A SLCO4C1 SDC1 MUC20	2.09e-05	184	135	6	04bd8ab5808fcfa923aa4d0edf6a7f88b7980122
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAP1GAP ACAN VCAN PCDH15 NLGN2 CTNND2	2.09e-05	184	135	6	278a7ed764c326450cb70e69ed2175980eaf5fe0
ToppCell	droplet-Lung-1m-Epithelial-alveolar_epithelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RAP1GAP RBPJL CELSR1 SLCO4C1 SDC1 HMGCLL1	2.09e-05	184	135	6	86c1551c4f7c7d0c35c14852b01b1e602fa5092a
Drug	2-lysophosphatidylcholine	F9 P4HB NFIC ACAN VCAN	2.45e-06	37	134	5	CID000086556
Drug	AC1NPPZW	CACNA1C CACNA1D SAV1 F9 NFIC PCDH15 NAV3	2.59e-06	103	134	7	CID005183170
Disease	Disorder of eye	FRAS1 KCNV2 CDHR1 RBP3 CRB1 VCAN PCDH15 MTTP MERTK	6.15e-07	212	135	9	C0015397
Disease	Retinitis Pigmentosa	IFT140 CDHR1 RBP3 CRB1 MERTK	1.19e-04	104	135	5	C0035334
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1C CACNA1D	1.24e-04	4	135	2	DOID:0060173 (implicated_via_orthology)
Disease	Leber Congenital Amaurosis	IFT140 CRB1 MERTK	1.35e-04	22	135	3	C0339527
Disease	alcohol consumption measurement	CACNA1C CACNA1D RELN MFSD6 ADGRB1 PPP1R13B CRB1 RANBP17 SNAP91 NFIA PKHD1 MTTP WDR90 CTNND2 SUFU CDH4	1.84e-04	1242	135	16	EFO_0007878
Disease	risk-taking behaviour	CACNA1C CACNA1D RELN ADGRB1 PPP1R13B NLGN1 ITIH3 MSH6 NFIA NFIC PCDH15 SORCS3	2.11e-04	764	135	12	EFO_0008579
Disease	hepatitis C virus infection, cirrhosis of liver	PKD1L1 MERTK	4.30e-04	7	135	2	EFO_0001422, EFO_0003047
Disease	Schizophrenia	IL10RA CACNA1C RELN CYP2E1 NLGN1 RB1CC1 CMYA5 ITIH3 PITPNM1 NLGN2 CTNND2 DNMT3L	7.66e-04	883	135	12	C0036341
Disease	cognitive impairment measurement	RAP1GAP NAV3 COL14A1	1.08e-03	44	135	3	EFO_0007998
Disease	kidney cancer (implicated_via_orthology)	SAV1 LLGL1	1.11e-03	11	135	2	DOID:263 (implicated_via_orthology)
Disease	status epilepticus (biomarker_via_orthology)	RELN NLGN1 ACAN NLGN2	1.17e-03	100	135	4	DOID:1824 (biomarker_via_orthology)
Disease	bipolar disorder	CACNA1C LAYN RBPJL PPP1R13B SYBU ITIH3 SNAP91 NFIA SUFU	1.39e-03	577	135	9	MONDO_0004985
Disease	liver cirrhosis (implicated_via_orthology)	FOCAD UTP4	1.57e-03	13	135	2	DOID:5082 (implicated_via_orthology)
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	PNPT1 PTPRQ	1.57e-03	13	135	2	C1846647
Disease	macula measurement	DCHS2 RBP3 FAT1 SNAP91 CTNND2	1.81e-03	189	135	5	EFO_0008375
Disease	HOMA-B	PCDH15 NAV3 FCRL5	2.07e-03	55	135	3	EFO_0004469
Disease	vascular endothelial growth factor measurement	KCNV2 L2HGDH PRKCH	2.17e-03	56	135	3	EFO_0004762
Disease	obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa	CACNA1C PPP1R13B ITIH3 SNAP91 SORCS3	2.32e-03	200	135	5	EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Disease	Alpha ketoglutarate measurement	KCNV2 TENM3	2.39e-03	16	135	2	EFO_0010457
Disease	Tinnitus	RB1CC1 PNPT1 PKHD1 SORCS3	3.05e-03	130	135	4	HP_0000360
Disease	comparative body size at age 10, self-reported	CACNA1D RELN RB1CC1 NPFFR1 FOCAD ACAN PKHD1	3.28e-03	420	135	7	EFO_0009819
Disease	susceptibility to cold sores measurement	MUC16 CTNND2 HMGCLL1	3.33e-03	65	135	3	EFO_0008402
Disease	bipolar disorder (is_marker_for)	RELN RAP1GAP	3.38e-03	19	135	2	DOID:3312 (is_marker_for)
Disease	familial hyperlipidemia (biomarker_via_orthology)	CYP2E1 MTTP	3.38e-03	19	135	2	DOID:1168 (biomarker_via_orthology)
Disease	Deaf Mutism	CACNA1D PCDH15	3.74e-03	20	135	2	C4082305
Disease	Deafness, Acquired	CACNA1D PCDH15	3.74e-03	20	135	2	C0751068
Disease	Hearing Loss, Extreme	CACNA1D PCDH15	3.74e-03	20	135	2	C0086395
Disease	Complete Hearing Loss	CACNA1D PCDH15	3.74e-03	20	135	2	C0581883
Disease	Bilateral Deafness	CACNA1D PCDH15	3.74e-03	20	135	2	C3665473
Disease	Prelingual Deafness	CACNA1D PCDH15	3.74e-03	20	135	2	C0011052
Disease	schizophrenia (implicated_via_orthology)	CACNA1D RELN NLGN2	3.78e-03	68	135	3	DOID:5419 (implicated_via_orthology)
Disease	mitochondrial DNA measurement	ANKLE1 ZBTB12 RB1CC1 RCL1 MUC22 SUFU	4.09e-03	328	135	6	EFO_0006312
Disease	serum metabolite measurement	RALGAPA1 CYP2C8 PKD1L1 L2HGDH SLC1A4 TENM3 NFIA ALDH1L2 PCDH15 SORCS3 FCRL5	4.19e-03	945	135	11	EFO_0005653
Disease	Manic Disorder	CACNA1C CACNA1D RELN	4.27e-03	71	135	3	C0024713
Disease	body weight loss	PKHD1 CDH4	4.52e-03	22	135	2	EFO_0005245

Protein segments in the cluster

Peptide	Gene	Start	Entry
DSATSILSSEFTGVQ	BEST3	521	Q8N1M1
GADVVFSATTTVTVN	CDHR1	221	Q96JP9
VTVGTTSFDDLIACV	ALG13	6	Q9NP73
SSDASFVTAVEVSGA	ANKLE1	216	Q8NAG6
TSAYLTIAGVESITV	CLSTN3	741	Q9BQT9
VTVPSDITTAFSSVD	VCAN	1201	P13611
TEVTFGEEVEKSTSV	VCAN	1566	P13611
FEGSGSVTSTTLIEI	VCAN	2321	P13611
DVILVGSSELSSSVS	DNMT3L	16	Q9UJW3
GISTFGEVEFTSLET	BDH1	146	Q02338
ATFAVDVLSTSSAIS	ADGRG4	311	Q8IZF6
TSFSFTGTESVQTVI	ADGRG4	561	Q8IZF6
VVASLATGTTETSVV	ADGRG4	1196	Q8IZF6
LTEADEASVFVVGTV	ADGRB1	816	O14514
AVALGFEDTEVTTTA	ADCY6	86	O43306
SSFLETTADVEEITG	BAZ2A	516	Q9UIF9
YFSTGETSVVELTAE	ALDH1L2	326	Q3SY69
VADLFVAGTETTSTT	CYP2C8	291	P10632
DVLAFGSGSVVDSVT	ACAP3	621	Q96P50
TTTTVTAVTAEVDLF	SNAP91	426	O60641
VQLTFSAGETTTTVA	CELSR1	1501	Q9NYQ6
DGSETETTSAILASV	CTNND2	41	Q9UQB3
SGAAIFASTISDIET	PPP1R13B	976	Q96KQ4
TVETFSVSSSVALDK	ATG2B	1261	Q96BY7
SGLLVDVFSDSASVV	AP2A2	681	O94973
SFVTSGVFSVTELVR	NFIA	216	Q12857
VAETTSGTFLSAELA	RCL1	246	Q9Y2P8
LETVATAGVVTSVAF	GPRC5A	31	Q8NFJ5
TSISEGLTTLDTVVS	RANBP17	916	Q9H2T7
IIGTESVEFSFSTSL	RBPJL	361	Q9UBG7
VTVADLFFAGTETTS	CYP2E1	291	P05181
EGSSVFFLDVTTLTL	LLGL1	156	Q15334
SVSASVFTLVAIAVE	NPFFR1	126	Q9GZQ6
GTTLTFDTELTVQTV	RB1CC1	11	Q8TDY2
IVTDTDTFSIDSVTG	FAT1	861	Q14517
DTFSIDSVTGVVNIA	FAT1	866	Q14517
ITATDGTFSSKAIVE	FAT1	2996	Q14517
AEEEGTTAETQTLTF	MUC16	3101	Q8WXI7
FGSSETTEIETVSSV	MUC16	4291	Q8WXI7
IETSAVLSEVSIGAT	MUC16	7261	Q8WXI7
RISSATEGSTVLSEV	MUC16	8426	Q8WXI7
VVEETEGSSFVTNLA	PCDHB13	36	Q9Y5F0
SVGVSVFTLTALSAD	NMBR	126	P28336
FSFTLSDGVSEVTQT	FRAS1	2286	Q86XX4
TVSLGNTAFTVSEDA	FRAS1	2796	Q86XX4
DEVTAIIASFSITSV	MERTK	151	Q12866
SRSASTSSFDIVIVG	L2HGDH	41	Q9H9P8
ITEVTASAETLSTAG	MUC20	471	Q8N307
ASSEVTTVFAAGSET	MUC22	571	E2RYF6
TTVFAAGSETIRAST	MUC22	576	E2RYF6
TVFETTTASTEGSEI	MUC22	681	E2RYF6
TGLETTTVFTIGSDT	MUC22	741	E2RYF6
NTAFIIGSESTIAST	MUC22	1486	E2RYF6
SGFVTLVSVESGFVT	LAYN	341	Q6UX15
SVTTSGEFSNDITEL	IQSEC2	446	Q5JU85
IQSATETIGSFLDST	ECPAS	791	Q5VYK3
TDTALGSFSEATVEV	FAT2	2246	Q9NYQ8
TLSSAEALTFEGATV	FCRL5	476	Q96RD9
SDTFTSEVVTFIVSV	OR5A2	191	Q8NGI9
ITTDITVDSSFVKAG	MTTP	786	P55157
SAEVTGTTELSAEVT	MUC19	5426	Q7Z5P9
SEATTFSGITEAVTV	MUC19	7766	Q7Z5P9
TFDSTVTTEVNGRTI	NAV3	716	Q8IVL0
SGSTVTFDIEAVTLG	CRLF3	376	Q8IUI8
VTEVEGTSFLTGIIS	F9	416	P00740
TFFGSEERTVTCVTV	PHRF1	951	Q9P1Y6
AELAAAAVGSSTTSI	TUBGCP2	106	Q9BSJ2
TRFSVDEVTLTVGSV	IL10RA	116	Q13651
AESLVESSEVAVIGF	P4HB	146	P07237
AVLTTDSATGETVVT	PRDM10	881	Q9NQV6
DSATGETVVTTDLLT	PRDM10	886	Q9NQV6
DYSTELSVTIAVGAS	NLGN1	711	Q8N2Q7
QASFSVVVAIDFGTT	HSPA12B	56	Q96MM6
IIGEFFSASSVTIVD	MFSD6	296	Q6ZSS7
GESTFFVELSETASI	MSH6	1186	P52701
SSGITFVDTSLVEVA	ACAN	1826	P16112
VTISTSTFFDGLLVT	RELN	76	P78509
FETLTTTGTVCGIDE	MIB1	276	Q86YT6
SAVTTEAGYIDSTIV	PTPRQ	326	Q9UMZ3
LSVDVTTTEAFDSGV	OSTN	26	P61366
LFEINSDTGEVVTTT	DCHS2	1771	Q6V1P9
STVVLSFSSGSIIVV	OR5P2	191	Q8WZ92
TTTTTLTVDVLDGDD	PCDH15	246	Q96QU1
ETVVFISAATNVVGS	OR8J1	196	Q8NGP2
VTEGFAESETFLTST	BOD1L1	1596	Q8NFC6
TAGVFNVTLSTEEIS	BPIFC	296	Q8NFQ6
VVSVSLISFGIQSSA	CACNA1C	996	Q13936
LGVEQVFTVESSAAS	PRMT7	421	Q9NVM4
DVVVTTTSGLSLAFD	FCGBP	2176	Q9Y6R7
ADVVVTTTSGLSLAF	FCGBP	3376	Q9Y6R7
SESEVVTAVGTTLDS	COL14A1	701	Q05707
EREEIASVSTGSAFV	CMYA5	581	Q8N3K9
SETVLTVAAFGVISF	ECSCR	116	Q19T08
TIAEDTAIGSTVDTL	FAT3	2716	Q8TDW7
FTINSETGDIVTVAA	CDH4	331	P55283
GSVVFSESFLTSQIL	DNAAF9	471	Q5TEA3
ATTLETVATEGVEVF	GGT5	221	P36269
SAFSVSSPAVVLETV	MAN2C1	946	Q9NTJ4
DETHFTVIITSVGLE	HEPACAM2	326	A8MVW5
STGFETLVVTSEDGI	ECI2	136	O75521
SSSFFVSSIRGTIIE	CCDC158	26	Q5M9N0
ISDIFTTIGSVTVAL	CRB1	1341	P82279
TITDIIVDFTGTLAE	CAPN6	181	Q9Y6Q1
TGLTALTTYTIEVAA	SDK2	956	Q58EX2
CSSEEVSSGITALVF	SCAP	1001	Q12770
GDFSVILVESSTFVS	CFAP47	2006	Q6ZTR5
AVAYISTTSTGSVDI	IFT140	31	Q96RY7
DTIVIAVSSTVAVFA	MEP1B	651	Q16820
DYSTELSVTVAVGAS	NLGN2	671	Q8NFZ4
TVFATDTDITFTAVT	PKD1L1	516	Q8TDX9
SLVSFGIQSSAISVV	CACNA1D	966	Q01668
VSIVSSTRLEESEGT	NEURL4	1081	Q96JN8
TSAFSAGIIEATEAE	FOCAD	1196	Q5VW36
TIISSVAAFTSVGVG	P2RX3	321	P56373
VVEETEGSSFVTNLA	PCDHB8	36	Q9UN66
TGLSVIEVTSFVSSR	HMGCLL1	111	Q8TB92
VAFLSDGTIISVDSA	UTP4	201	Q969X6
SVDVIVSSAFLLTIS	PHTF2	631	Q8N3S3
ETVSATFIDSSGQFV	NXPE3	36	Q969Y0
SFTFLAEGTDTITVQ	SORCS3	966	Q9UPU3
TAFITNFTLTIDGVT	ITIH3	86	Q06033
AIGVASSTFVLVSVV	KCNV2	261	Q8TDN2
SASSFASVVEETEGV	RAP1GAP	571	P47736
FTFETSGENTAVVAV	SDC1	211	P18827
ILTSSASVIFEGVDI	NSDHL	141	Q15738
VSVTSGFVDVFSSVN	PKHD1	3431	P08F94
KVASVASTLETTFET	IARS2	336	Q9NSE4
TTFETISTLSGVDLE	IARS2	346	Q9NSE4
VTSGVFSVTELIQVS	NFIC	221	P08651
GVTISQVDEETFSVF	PNPT1	636	Q8TCS8
TIEESESTETTGVAF	ADGRE1	466	Q14246
ESTETTGVAFVSFVG	ADGRE1	471	Q14246
TSVAGFIVVTSVDLE	CLP1	381	Q92989
TEGITSDSLVAETSI	CKAP2L	606	Q8IYA6
DGKTVTSTDVDIVFS	TPPP2	41	P59282
EAVVFSIDGSFTASV	PITPNM1	1021	O00562
GSSQSFVTEVSFAVE	SAV1	111	Q9H4B6
GSVSFTDVTVDFTQE	ZFP1	6	Q6P2D0
SETGFRTISSLEEIV	TMEM192	221	Q8IY95
VALTTVAFSTDGQTV	WDR90	1526	Q96KV7
DGVSEASLVSSISAT	ZBTB12	136	Q9Y330
FLEAYTTGTAVETSV	VPS13A	1521	Q96RL7
FSAEVATITGSESAS	RALGAPA1	976	Q6GYQ0
ILTSSVTAGTAEEFT	RBP3	1141	P10745
LFDEIVTATTTESGD	SYBU	441	Q9NX95
IFTILVTATASSVGA	SLC1A4	406	P43007
KTEITSTAETFGFEA	SLCO4C1	551	Q6ZQN7
ITFVSTGVEGAFATE	SUFU	406	Q9UMX1
TVTSGDLDLFTEQTT	SMAP1	276	Q8IYB5
TLESATAIAVSYSGV	TENM3	1401	Q9P273
ATTGAVVTISASLVA	TMEM130	41	Q8N3G9
VEVSVLGSEAFSSGV	TRIM62	336	Q9BVG3
FVATGSSEVLVFDTT	WDR87	386	Q6ZQQ6
FVVITLTGSFTEATL	PRKCH	131	P24723